相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Bone Scan
Arnold I. Brenner et al.
SEMINARS IN NUCLEAR MEDICINE (2012)
Imaging of the Thyroid in Benign and Malignant Disease
Charles M. Intenzo et al.
SEMINARS IN NUCLEAR MEDICINE (2012)
Protein scaffold-based molecular probes for cancer molecular imaging
Zheng Miao et al.
AMINO ACIDS (2011)
Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging
Boonchoy Soontornworajit et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging
William M. Rockey et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Molecular imaging in cancer treatment
Mark H. Michalski et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Actinium-225 in Targeted Alpha-Particle Therapeutic Applications
David A. Scheinberg et al.
CURRENT RADIOPHARMACEUTICALS (2011)
Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates
Jung Heon Lee et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
J. Lofblom et al.
FEBS LETTERS (2010)
Engineered affinity proteins for tumour-targeting applications
Mikaela Friedman et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2009)
Dual Time Point C-11 Acetate PET Imaging Can Potentially Distinguish Focal Nodular Hyperplasia From Primary Hepatocellular Carcinoma
Li Huo et al.
CLINICAL NUCLEAR MEDICINE (2009)
Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?
Dominic A. X. Schinagl et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Recommendations on the use of F-18-FDG PET in oncology
James W. Fletcher et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Hypoxia in prostate cancer: observation to intervention
Yaacov Richard Lawrence et al.
LANCET ONCOLOGY (2008)
PET versus SPECT: strengths, limitations and challenges
Arman Rahmim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2008)
Nanotechnology and aptamers: applications in drug delivery
Etgar Levy-Nissenbaum et al.
TRENDS IN BIOTECHNOLOGY (2008)
Targeted therapy in nuclear medicine-current status and future prospects
W. J. G. Oyen et al.
ANNALS OF ONCOLOGY (2007)
Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer
Anca-Ligia Grosu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
HER2 testing: a review of detection methodologies and their clinical performance
Jennifer Laudadio et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)
Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy
Vladimir Tolmachev et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Immuno-PET: A navigator in monoclonal antibody development and applications
Guus A. M. S. van Dongen et al.
ONCOLOGIST (2007)
How molecular imaging is speeding up antiangiogenic drug development
Weibo Cai et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer
Joseph G. Rajendran et al.
CLINICAL CANCER RESEARCH (2006)
Current concepts - Positron-emission tomography and assessment of cancer therapy
ME Juweid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Targeted cancer therapy using radiolabeled monoclonal antibodies
WA Bethge et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2005)
Cancer therapy with radiolabeled and drug/toxin-conjugated antibodies
SV Govindan et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2005)
First clinical experience with α-emitting radium-223 in the treatment of skeletal metastases
S Nilsson et al.
CLINICAL CANCER RESEARCH (2005)
Cancer radioimmunotherapy with alpha-emitting nuclides
O Couturier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Clinical relevance of imaging proliferative activity in lung nodules
AK Buck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Targeting of radio-isotopes for cancer therapy
DE Milenic et al.
CANCER BIOLOGY & THERAPY (2004)
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer
MI Milowsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The radioisotope contributes significantly to the activity of radioimmunotherapy
TA Davis et al.
CLINICAL CANCER RESEARCH (2004)
Radiotoxicity of iodine-125 and other Auger-electron-emitting radionuclides: Background to therapy
SJ Adelstein et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2003)
Nuclear medicine applications in molecular imaging
FG Blankenberg et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2002)
Molecular imaging of cancer with positron emission tomography
SS Gambhir
NATURE REVIEWS CANCER (2002)
Pivotal study of iodine I 131 Tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
MS Kaminski et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
